Prime Capital Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$663K Sell
8,470
-1,543
-15% -$124K 0.01% 624
2026
Q1
$868K Sell
10,013
-168
-2% -$16.1K 0.01% 534
2025
Q4
$978K Sell
10,181
-525
-5% -$51K 0.01% 501
2025
Q3
$1.02M Buy
10,706
+5
+0% +$460 0.01% 485
2025
Q2
$933K Sell
10,701
-3,013
-22% -$256K 0.01% 477
2025
Q1
$1.23M Buy
13,714
+2,453
+22% +$220K 0.01% 461
2024
Q4
$900K Sell
11,261
-11,028
-49% -$955K 0.01% 442
2024
Q3
$2.01M Sell
22,289
-22,854
-51% -$1.92M 0.03% 312
2024
Q2
$3.55M Sell
45,143
-442
-1% -$36.2K 0.05% 236
2024
Q1
$3.97M Buy
45,585
+3,225
+8% +$275K 0.06% 226
2023
Q4
$3.49M Buy
42,360
+36,212
+589% +$2.76M 0.05% 246
2023
Q3
$482K Buy
6,148
+305
+5% +$25.5K 0.01% 474
2023
Q2
$515K Buy
+5,843
New +$503K 0.01% 470
2023
Q1
Sell
-5,277
Closed -$410K 615
2022
Q4
$410K Buy
+5,277
New +$428K 0.02% 363
2021
Q4
Sell
-27,528
Closed -$3.45M 359
2021
Q3
$3.45M Buy
+27,528
New +$3.56M 0.22% 92
2021
Q2
Sell
-1,005
Closed -$119K 478
2021
Q1
$119K Sell
1,005
-97
-9% -$11.4K 0.01% 274
2020
Q4
$129K Sell
1,102
-269
-20% -$29.6K 0.01% 261
2020
Q3
$142K Sell
1,371
-227
-14% -$22.8K 0.01% 256
2020
Q2
$147K Sell
1,598
-103
-6% -$9.88K 0.01% 244
2020
Q1
$153K Buy
1,701
+262
+18% +$27.9K 0.02% 211
2019
Q4
$163K Buy
1,439
+303
+27% +$33.2K 0.02% 207
2019
Q3
$123K Buy
+1,136
New +$119K 0.02% 229
2019
Q1
Sell
-163
Closed -$15K 402
2018
Q4
$15K Buy
+163
New +$15.2K 0.01% 238
2018
Q3
Sell
-35
Closed -$3K 317
2018
Q2
$3K Buy
+35
New +$2.92K ﹤0.01% 312

Other funds holding MDT

Prime Capital Investment Advisors's MDT Position: Q2 2026 in Review

Prime Capital Investment Advisors reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $124K and leaving 8,470 shares worth $663K. The position accounts for 0.01% of the portfolio, ranked #624.

Prime Capital Investment Advisors first reported a position in MDT in Q2 2018 and has held it in 24 quarters since. The position peaked at $3.97M in Q1 2024. 1,667 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Prime Capital Investment Advisors held 8,470 shares of Medtronic worth $663K as of Q2 2026.
  • Prime Capital Investment Advisors sold 1,543 Medtronic shares in Q2 2026, an estimated $124K.
  • Medtronic made up 0.01% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #624 holding.
  • Prime Capital Investment Advisors first reported a position in Medtronic in Q2 2018 and has held it in 24 quarters since.
  • Prime Capital Investment Advisors's Medtronic position peaked at $3.97M in Q1 2024.
  • 1,667 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.